Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE AD1) - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis

Clinical trial NCT03745638 · COMPLETED

Trial details

NCT number

NCT03745638

Sponsor

Incyte Corporation

Status

COMPLETED

Phase

Phase 3

Study type

INTERVENTIONAL

Start date

2018-12-20

Primary completion

2019-12-23

Enrollment

631

View on ClinicalTrials.gov